Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Capital Southwest Corporation (NASDAQ:CSWC) Stock Touches 52-Week High Despite EPS Dip on Portfolio Expansion

Headquartered in Dallas, Texas,CapitalSouthwest is a closed-end fund and internally managed business development company providingDebtandEquitycapital to lower middle-market companies with enterprise values typically between USD 10 million and USD 150 million. The company's portfolio spans first lien, second lien, and equity investments across healthcare, …

Nitish Kishor | 26 August 2026

Quest Diagnostics Incorporated (NYSE:DGX) Stock Hits 52-Week High on New Roche Alzheimer's Testing Deal

Headquartered in Secaucus, New Jersey, Quest Diagnostics operates one of the largest networks of clinical laboratories in the United States, providing testing services to physicians, hospitals, employers, health plans, and patients. The company's offerings span routine blood tests, esoteric and genetic testing, occupational health …

Nitish Kishor | 26 August 2026

Expeditors International of Washington, Inc. (NYSE:EXPD) Stock Hits 52-Week High on Record Airfreight-Led Earnings

Headquartered in Bellevue, Washington, Expeditors International provides comprehensiveSupplychain solutions spanning airfreight, ocean freight, customs brokerage, trucking, warehousing, distribution, and order management. The company operates as a non-asset-based provider, meaning it does not own ships, planes, or trucks, instead leveraging carrier relationships and proprietary technology …

Nitish Kishor | 26 August 2026

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock Surges to 52-Week High on Record ENHANZE Royalty Revenue

Headquartered in San Jose, California, Halozyme Therapeutics is a biotechnology company focused on enabling subcutaneous delivery ofBiologicsthrough its proprietary ENHANZE drug delivery technology. The platform uses recombinant human hyaluronidase to temporarily break down hyaluronan in subcutaneous tissue, allowing large volumes of drugs to be …

Nitish Kishor | 26 August 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock Hits 52-Week High as clonoSEQ MRD Testing Growth Accelerates

Adaptive Biotechnologies develops and commercializes immune-driven diagnostics and drug discovery technologies, with its clonoSEQ test serving as a leading minimal residual disease assay used in blood cancer monitoring. The company's platform leverages its proprietary immune sequencing technology to detect minimal residual disease with high …

Nitish Kishor | 26 August 2026

Abercrombie & Fitch Company (NYSE:ANF) Stock Soars 50% Intraday to 52-Week High on Tariff Refund Windfall

Headquartered in New Albany, Ohio, Abercrombie & Fitch operates through multiple brands including Abercrombie & Fitch, abercrombie kids, Hollister Co., and Gilly Hicks, serving customers through retail stores, e-commerce, andFranchiseagreements across more than 70 countries. The company has undergone a substantial brand transformation in …

Nitish Kishor | 26 August 2026

Ategrity Specialty Insurance Company Holdings (NYSE:ASIC) Stock Climbs to 52-Week High on New Product Launches

Ategrity Specialty Insurance Company Holdings is a specialty insurance provider focused on serving small and medium-sized businesses through casualty, property, and management and professionalLiabilitylines. The company's differentiated approach centers on a productionizedUnderwritingmodel combining specialized expertise, centralized governance, account-level analytics, and streamlined workflows designed to …

Nitish Kishor | 26 August 2026

Axogen, Inc. (NASDAQ:AXGN) Stock Reaches 52-Week High as Nerve Repair Revenue Jumps 23%

Headquartered in Alachua, Florida, Axogen develops and commercializes products for the treatment of peripheral nerve injuries. The company's flagship product, Avance Nerve Graft, is a processed nerve allograft used for surgical repair of damaged peripheral nerves, complemented by the AxoGuard Nerve Protector and AxoGuard …

Nitish Kishor | 26 August 2026

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Climbs to 52-Week High on T-Cell Engager Pipeline Progress

Cullinan Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapies for cancer. The company's pipeline centers on T cell engagers CLN-978 and CLN-049, alongside a licensed velinotamig program from Genrix and a continued collaboration with Taiho on zipalertinib, leveraging …

Nitish Kishor | 26 August 2026

Box, Inc. (NYSE:BOX) Stock Hits 52-Week High as Enterprise Advanced Adoption Drives Fifth Straight Growth Quarter

Headquartered in Redwood City, California, Box provides cloud-based content management, collaboration, and workflow solutions serving over 100,000 organizations globally, including more than 70 percent of Fortune 500 companies. The company's Enterprise Advanced offering provides enhanced security, governance, and compliance features for large organizations, while …

Nitish Kishor | 26 August 2026
Support

Hi! How can we help you today?

Loading…